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Aspergi l lus fumigatus causes l i fe-threatening opportunist ic infect ions in
immunocompromised patients. As therapeutic outcomes of invasive aspergillosis (IA) are
oftenunsatisfactory, thedevelopmentof targeted immunotherapy remainsan important goal.
Linking the innate and adaptive immune system, dendritic cells are pivotal in anti-Aspergillus
defense and have generated interest as a potential immunotherapeutic approach in IA.While
monocyte-derived dendritic cells (moDCs) require ex vivo differentiation, antigen-pulsed
primary myeloid dendritic cells (mDCs) may present a more immediate platform for
immunotherapy. To that end, we compared the response patterns and cellular interactions
of human primary mDCs and moDCs pulsed with an A. fumigatus lysate and two
A. fumigatus proteins (CcpA and Shm2) in a serum-free, GMP-compliant medium. CcpA
and Shm2 triggered significant upregulation of maturation markers in mDCs and, to a lesser
extent, moDCs. Furthermore, both A. fumigatus proteins elicited the release of an array
of keypro-inflammatory cytokines includingTNF-a, IL-1b, IL-6, IL-8, andCCL3 frombothDC
populations. Compared to moDCs, CcpA- and Shm2-pulsed mDCs exhibited greater
expression of MHC class II antigens and stimulated stronger proliferation and IFN-g
secretion from autologous CD4+ and CD8+ T-cells. Moreover, supernatants of CcpA- and
Shm2-pulsed mDCs significantly enhanced the oxidative burst in allogeneic neutrophils co-
cultured with A. fumigatus germ tubes. Taken together, our in vitro data suggest that ex vivo
CcpA- and Shm2-pulsed primary mDCs have the potential to be developed into an
immunotherapeutic approach to tackle IA.
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Page et al. Antigen-Pulsed mDCs Induce Anti-Aspergillus ResponseINTRODUCTION
Aspergillus fumigatus remains the most common mold pathogen
causing life-threatening infections in immunocompromised patients
such as hematopoietic stem cell transplant (HSCT) recipients.
Mortality rates of invasive aspergillosis (IA) are up to 80%, mainly
due to the limited efficacy of current diagnostic and therapeutic
strategies. To meet the need for more specific therapeutic options, a
spectrum of immunotherapeutic approaches have been developed to
enhance host defence and support fungal clearance (1).
Dendritic cells (DCs) are an important cornerstone in the host
response to A. fumigatus and have been proposed as a potential
immunotherapeutic tool in IA. Highly phagocytic immature DCs
patrol their environment and recognize pathogenic antigens via
pattern recognition receptors (PRRs). Activated DCs present
processed antigens to CD4+ and CD8+ T-cells and orchestrate
the response of other innate and adaptive immune cell subsets
through cytokine release and co-stimulatory surface receptors (2).
Ex vivo A. fumigatus antigen-pulsedmurine DCs have been shown
to induce TH1 priming and confer protection against experimental
IA (3). Similarly, DCs pulsed with live A. fumigatus or transfected
with fungal RNA accelerated functional recovery of antifungal
TH1 immunity in a murine HSCT model and had significantly
greater therapeutic efficacy against murine IA compared to
adoptive T-helper cell transfer (4).
Although distinct DC subsets differ in their potential to recognize
fungal antigens via PRRs and display disparate phagocytic capacity,
direct interaction studies revealed similar cytokine responsepatterns of
monocyte-derived DCs (moDCs) and myeloid DCs (mDCs) upon
confrontation with A. fumigatusmorphotypes (5, 6). Of note, mDCs
showed more pronounced MHC class II expression in response to A.
fumigatus germ tubes than moDCs (5) and may therefore provide an
appealing tool to augment anti-Aspergillus T-cell responses in
immunocompromised patients. Despite their low abundance, mDCs
can be readily isolated from whole blood or leukapheresate, whereas
moDCs need to be induced through cytokine treatment of monocytes
for a minimum of three days. As early therapeutic interventions are
crucial to improve the outcome of IA (7), the immediate availability of
mDCs may provide an important advantage for immunotherapeutic
approaches.However, comparative studies of the functional properties
of ex vivo A. fumigatus antigen-pulsed mDCs and moDCs and their
interactions with other innate and adaptive immune cell subsets
are scarce.
Moreover, the comparative stimulatory capacity of different
classes of antigens in DCs is poorly understood. Ex vivo stimulation
of DCs can be achieved with pathogen lysates, proteins, or peptides.
Mycelial lysates contain complex and partially undefined
components, such as cell wall proteins, glycostructures, lipids, and
secondarymetabolites, including immune-inhibitorymetabolites (8).
In contrast to lysates, a broad spectrum of proteins of a well-defined
quality are available. Compared to individual peptides, proteins
harbor a variety of antigens that can be presented by DCs to other
immune cells, therefore initiating amore complex immune response
thanpeptides. In this study,wecompared exvivopulsingofmDCand
moDCwith anAspergillus lysate and two proteins (CcpA and Shm2)
that were recently identified as immunogenic Aspergillus antigens
(9–11).We found that, in contrast to the lysate, these proteins reliablyFrontiers in Immunology | www.frontiersin.org 2induce mDC-maturation and stimulate the release of pro-
inflammatory cytokines and chemokines. Furthermore, antigen-
pulsed mDCs elicited autologous T-cell proliferation, IFN-g
secretion, and enhanced the anti-Aspergillus oxidative burst of
neutrophils. Importantly, protein-pulsed mDCs exhibited more
pronounced maturation and greater T-cell stimulatory capacity
than moDCs, suggesting the immunotherapeutic potential of




frame of shm2 cDNA or a synthetic gene encoding for CcpA of A.
fumigatus were amplified and cloned into the expression vector
pET43.1H6 and pET28aH6TEV, respectively, for recombinant
expression as His-tagged proteins. Proteins were purified by
metal chelate affinity chromatography (Äkta explorer purification
system, GE Healthcare). Protein concentrations were determined
by measuring absorbance at 280 nm (NanoDrop 1000, Thermo
Scientific) or by a Bradford protein assay (Biorad). Endotoxin
contamination was determined (LAL Chromogenic Kit, Thermo
Scientific) and reduced to<0.1EU/mlusing resincolumns (Thermo
Scientific). Research grade A. fumigatus lysate (AfuLy) was
purchased from Miltenyi Biotec. To generate A. fumigatus germ
tubes, 2×107 conidia of strainATCC46645were incubated in20mL
RPMI, supplementedwith 120 µg/mL gentamicin, for 9 h at 25°C in
a shaking incubator (Infors HT, 200 rpm), pelleted at 5000 g for
10 min, and resuspended in RPMI + 5% FCS.
Isolation and Generation of Dendritic
Cell Subsets
Human peripheral blood mononuclear cells (PBMC) were obtained
from leukocyte reduction chambers using Ficoll-Hypaque
(Biochrome AG) density gradient centrifugation. Thereafter,
mDCs were isolated from PBMCs by CD19 depletion followed by
CD1c positive selection (Myeloid Dendritic Cell Isolation Kit,
Miltenyi Biotec). Monocyte isolation from PBMCs was performed
usingMACS CD14 positive selection (Miltenyi Biotec). ThemoDCs
were generated by incubation of monocytes with 20 ng/mL IL-4 and
100 ng/mL GM-CSF for 6 days as previously described (12). A
minimum purity of ≥ 95% CD1c+ mDCs or CD14- CD1a+ moDCs
was confirmed by flow cytometry (FACS Calibur, Becton
Dickinson, antibodies from Miltenyi Biotec). Furthermore, we
confirmed at least 4-fold induction of the maturation markers
CD80 and CD86 upon overnight stimulation with ultrapure LPS
to validate the functionality of our DC preparations.
Isolation of Polymorphonuclear
Granulocytes (PMNs)
After obtaining informed consent, 15 mL venous EDTA blood was
collected from healthy adult donors. PMNs were isolated using
PolymorphPrep (Axis-Shield) gradient centrifugation according to
the manufacturer’s instructions, except that Buffer EL (Qiagen)
was used instead of Solution C. PMNs were suspended in RPMIMay 2021 | Volume 12 | Article 659752
Page et al. Antigen-Pulsed mDCs Induce Anti-Aspergillus Response1640 + 10% FCS at a concentration of 3×106/mL and the purity of
the PMN suspension was verified by flow cytometry (CD3-
PerCP-/CD66b-FITC+/CD14-PElow cells > 90%, antibodies from
Miltenyi Biotec).
Flow Cytometric Analysis of DCMaturation
6×105 mDCs or moDCs were cultured for 18 h at 37°C in 200 µL
CellGro GMP DC medium (CellGenix, Cat. No.: 20801-0500)
supplemented with 50 µg/mL AfuLy, 1-5 µg/mL Aspergillus
proteins CcpA or Shm2, 1 µg/mL LPS (Sigma, positive
control), or plain medium (negative control). Thereafter, DCs
were stained with anti-CD1a-APC (moDCs) or anti-CD1c-APC
(mDCs), anti-CD14-FITC, anti-CD80-APC, anti-CD83-PE,
anti-CD86-FITC, anti-CD40-FITC, anti-HLA-ABC-PE, anti-
HLA-DR-PE (BD), and anti-CCR7-APC (Miltenyi Biotec) in
three different panels. Samples were analyzed using a FACS
Calibur cytometer (BD), Cell Quest Pro software (BD), and Flow
Jo software (version 10.6.2.). Dead cells were excluded from
analysis by light scatter (FSC/SSC) properties.
Analysis of Cytokine Release by Multiplex
Cytokine Assays
6×105 moDCs or mDCs were incubated for 18 h in plain CellGro
medium (unstimulated control) or in 200 µL medium containing
50 µg/ml AfuLy, 5 µg/mL of A. fumigatus proteins CcpA or Shm2,
1 µg/mLultrapure LPS (Invivogen), 100 µg/mLbeta-glucan (Merck
Millipore), or 6×105 ethanol-inactivated A. fumigatus germ tubes.
The supernatants were then collected and analyzed using a
ProcartaPlex Human 8-plex plate assay (Thermo Scientific).
IFN-g ELISpot
Pulsing ofmoDCs andmDCswith antigenswas performed for 18 h
in 200 µL CellGro medium as described above. After pulsing, DCs
were washed twice with CellGro to remove residual antigens. An
ELISpot culture plate (Millipore) was washed 3 times with 200 µL
PBS and coated with an IFN-g capture antibody (1-D1K, BD), then
incubated overnight at 4°C. The platewas thenwashed 5 timeswith
PBS and blocked with CellGro medium for 3 h at 37°C. After
removal of the medium, 5×105 freshly isolated autologous T-cells
(pan T-cell Isolation Kit, Miltenyi Biotec) were seeded in each well.
Cells were stimulated with SEB +a-CD3 (1 µg/ml respectively, as a
positive control) or 5×104 autologous,A. fumigatus antigen-pulsed
mDCs (T-cell-DC ratio 10:1). The ELISpot plate was incubated for
18 h at 37°C and subsequently washed 6 times with PBS. IFN-g
producing cells were stained for 2 h with an IFN-g detection
antibody (7-B6-1 biotin, BD) at RT, followed by another 5 PBS
washing steps. After 1 h of incubation with a streptavidin-linked
phosphatase (Southern Biotec) at RT, plates were washed 8 times
with PBS and developed for 25 min with an NBT/BCIP substrate
(Sigma). The staining process was stopped by rinsing the plate with
water and spot counts were determined with an Immunospot S2A
Core Analyzer ELISpot reader (CTL).
T-Cell Proliferation Assay
The capacity of antigen-pulsedmDCs andmoDCs to activateT-cell
proliferation was evaluated by a carboxyfluorescein succinimidyl
ester (CFSE)-based flow cytometry assay. DCs were pulsed withFrontiers in Immunology | www.frontiersin.org 3Aspergillus antigens for 18 h and washed twice with CellGro
medium as described above. 5×104 mDCs were co-cultured with
5×105 autologous pan T-cells (1:10), stained with CFSE (5 µM, Life
Technologies), in 550 µL CellGro medium for 6 days at 37°C.
During this incubation, the remaining antigen-pulsed DCs were
cryopreserved in 5CS-CryoStor medium (Stem Cell Technologies)
at -80°C. Following restimulationwith thawed antigen-pulsedDCs,
T-cellswere cultured for 6 additional days at 37°Cand subsequently
stained with fluorescently-labeled a-CD4 and a-CD8 antibodies
(Miltenyi Biotec). The fraction of T-cells displaying reduced CFSE
content compared to an unstimulated control was determined by
flow cytometry.
Stimulation of the Neutrophilic Oxidative
Burst by DC Supernatants
6×105 mDCs or moDCs were incubated in 200 µL CellGenix
medium containing 50 µg/mL AfuLy, 5 µg/mL CcpA or 5 µg/mL
Shm2, or in antigen-free medium for 18 h. Culture supernatants
were sterile-filtered (0.2 µm) and cryopreserved at -80°C until
further use.
In a 96-well plate, 1×105 PMNs were combined with 5×104
A. fumigatus ATTC 46645 germ tubes (in a total of 50 µL RPMI +
5% FCS) or were seeded in 50 µl RPMI + 5% FCS without addition of
fungal cells. Thereafter, 33.3 µL of plain CellGenixmedium or thawed
DCsupernatantsdiluted1:4with freshCellGenixmediumwereadded,
containing themetabolites releasedby2.5×104DCs(PMN-DC-ratioof
4:1). To quantify the release of reactive oxygen species, 16.7 µL
dichlorofluorescein (DCF) solution was added (final concentration,
15 µg/mL). Thereafter, the plate was incubated for 2 hours in a
temperature-controlled (37°C) SpectraMax iD3 Microplate Reader
(Molecular Devices) and fluorescence was read every 5 min at an
excitation and emission wavelength of 485 nm and 535 nm,
respectively. Area-under-the-curve of time/relative fluorescence
curves was calculated as a surrogate for the anti-Aspergillus oxidative
burst. DC supernatants from three donorswere combinedwithPMNs
from three allogeneic donors for nineDC/PMN combinations. PMNs
stimulated with phorbol 12-myristate 13-acetate (PMA, 10 ng/mL)
were used as a positive control. PMN seeding density, DCF
concentration, and multiplicity of infection were optimized in
preceding experiments (unpublished data).
Statistics
Significance testing was performed using the two-tailed, paired
Student’s t-test or one-way repeated measures analysis of
variance (RM ANOVA) with Dunnett’s post-hoc test, as
detailed in the figure legends. Data were analyzed and
visualized using Microsoft Excel and GraphPad Prism 8.RESULTS
CcpA and Shm2 Induce Time- and
Concentration-Dependent mDC
Maturation and Upregulation of
Co-Stimulatory Molecules
Maturation of DCs is necessary for efficient activation of adaptive
immune cells (13). Therefore, we first assessed the ability ofMay 2021 | Volume 12 | Article 659752
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maturation of mDCs and moDCs. After 18 h of stimulation,
limited induction of CD40, CD80 and CD86 was found in
moDCs stimulated with the proteinaceous antigens, whereas
stimulation with the lysate did not alter surface expression of
the maturation markers and co-stimulatory molecules that were
tested (Figure 1A). While the lysate showed minimal stimulatory
capacity in mDCs, Shm2 and CcpA induced greater upregulation
(1.8-25.2-fold MFI) of all maturation markers tested compared
with the unstimulated control (Figure 1A). CcpA led to a
stronger induction of the co-stimulatory molecules CD80 and
CD83 than Shm2 and elicited an 11-fold upregulation in the cell
surface expression of homing receptor CCR7 on mDCs. For both
CcpA and Shm2 stimulation, upregulation of maturation marker
expression on the surface of mDCs was concentration-dependent
(Figure 1B). For Shm2, we also evaluated the temporal kinetics
of maturation marker expression by comparing mDCs exposed
to 1 and 5 µg/mL Shm2 for 6 versus 18 hours. Except for the early
activation marker CD83 (14), all differentially expressed markers
showed more pronounced upregulation after overnight Shm2
stimulation (Figure 1C).
Shm2 and CcpA Stimulate the Release of
an Array of Pro-Inflammatory Cytokines
From mDCs and moDCs
DCs secrete a broad spectrum of cytokines and chemokines
orchestrating the response of other immune cell populations (15).
Therefore, we stimulatedmDCs andmoDCswith Shm2, CcpA, and
AfuLy for 18 h and compared cytokine concentrations in the culture
supernatants with an 8-plex Luminex assay. Without stimulation,
bothDCsubsets released consistently lowamountsofTNF-a, IL-1b,
and IL-12 p70, whereas baseline secretion > 10 pg/mL was seen for
IL-6, CCL2 (MCP1), andCCL3 (MIP-1a) inmoDCs and for IL-8 in
bothDCpopulations (Figure2).AfuLyhadno significant impacton
cytokine release in either subset. Shm2 and CcpA strongly induced
all tested cytokines (Figure 2) except IL-17A (data not shown) in
both DC populations. While both protein antigens elicited higher
levels of TNF-a (5.1-9.7 ng/mL) and IL-12 p70 (320-841 pg/mL) in
moDCs than in mDCs, stronger induction of IL-1b (65-81 pg/mL),
IL-6 (85-92ng/mL), andCCL3 (1.5-2.4 ng/mL)was found inmDCs.
Shm2 and CcpA induced greater absolute levels of CCL2 inmoDCs
than in mDCs, whereas relative induction compared to the
unstimulated control was greater in mDCs.
Importantly, these minor quantitative differences in cytokine
release by both DC subsets after Shm2 and CcpA stimulation
were partially decoupled from cytokine responses elicited by PRR
agonists (ultrapure LPS or beta-glucan) and inactivated A.
fumigatus germ tubes (Figure S1). For example, higher
concentrations of IL-6 and CCL3 (MIP-1a) were found in
response to the PRR agonists and germ tubes, whereas Shm2
and CcpA induced stronger release of these cytokines by mDCs.
Antigen-Pulsed mDCs and moDCs
Stimulate IFN-g Secretion and Proliferation
of Autologous T-Cells
Next, we assessed the capacity of mDCs and moDCs pulsed with
Aspergillus antigens to drive IFN-g secretion from autologousFrontiers in Immunology | www.frontiersin.org 4T-cells, a cytokine that is implicated in protective immunity to
fungal infections (16–18). Therefore, DCs were stimulated for
18 h with Shm2, CcpA, or AfuLy, washed, and co-cultured with
autologous T-cells in an IFN-g ELISpot plate (Figure 3A).
Compared to unstimulated mDCs, pulsing with CcpA, Shm2,
and AfuLy caused significant induction of IFN-g secretion by
autologous T-cells (Figures 3B, C). Interestingly, despite less
pronounced upregulation of maturation markers compared with
mDCs (Figure 1A), Shm2- and CcpA-pulsed moDCs also
stimulated T-cells to release IFN-g (Figures 3B, C). For AfuLy,
an even stronger response was seen in moDC- than in mDC-co-
cultures (Figure 3C). However, the strongest IFN-g response was
elicited by CcpA-pulsed mDCs (Figure 3C). Importantly, no
direct induction of IFN-g spot formation was seen in T-cell
monocultures stimulated with the antigens (data not shown),
precluding that spot formation in co-cultures was due to
unprocessed antigens remaining in the medium after
harvesting and washing of DCs.
To corroborate that antigen-pulsedmDCs induce autologousT-
cell activation, we quantified the frequencies of proliferating CD4+
and CD8+ cells with a flow cytometric CFSE-based assay
(Figure 3A). T-cells alone or T-cells co-cultured with
unstimulated mDCs showed low proliferation rates of 1.0-5.2%,
whereas mDCs pulsed with Shm2, CcpA, and AfuLy induced
significant proliferation of CD4+ T-helper cells (10.3-24.6%) and
cytotoxic CD8+ T-cells (10.9-15.5%, Figure 3D). While
unstimulated moDCs induced stronger T-cell proliferation than
mDCs, antigen loading ofmDCs elicited greater relative changes in
T-cell proliferation, particularly for CD8+ T-cells.
Supernatants of Shm2- and CcpA-Pulsed
mDCs Enhance the Aspergillus-Induced
ROS Release of PMNs
In addition to their impact onT-cell activationandproliferation,we
compared the capacity of supernatants from antigen-pulsedmDCs
and moDCs to enhance the anti-Aspergillus oxidative burst of
PMNs (Figure 4A). Regardless of antigen pulsing, baseline ROS
secretionofunstimulatedPMNs in thepresenceofDCsupernatants
remained consistently low (fold change, 0.94-1.16, Figure 4B).
With germ tube stimulation, we observed at least a 3.6-fold
increase in ROS release after 2-hours with all supernatants.
Although unstimulated moDC supernatants caused a greater
neutrophilic ROS response to the germ tubes than unstimulated
mDC supernatants, a stronger relative increase in ROS release was
observed with supernatants from mDC when pulsed with protein
antigens, especially with CcpA (+62%, Figure 4B, right panel). In
contrast, pulsing of DCs with the lysate reduced the stimulatory
capacity of their supernatants on the neutrophilic ROS response.DISCUSSION
Dendritic cells are pivotal in mounting an innate and adaptive
immune response against A. fumigatus and are considered a
potential tool for anti-Aspergillus immunotherapy (19, 20). Because
of their ability topresent antigens to initiate thegenerationof antigen-
specific CD4+ and CD8+ T-cell responses, ex vivo-generated DCsMay 2021 | Volume 12 | Article 659752
Page et al. Antigen-Pulsed mDCs Induce Anti-Aspergillus Responsehave been applied in antiviral and antitumor vaccine strategies (21–
23). One of the few clinical studies to have exploited primary CD1c+
mDCs used them for the treatment of metastatic melanoma (24).
These authors showed that therapeutic vaccinationwith less than 107
mDCs is feasible andwithout substantial toxicity. Four of 14 patients
showed long-term progression-free survival (12-35 months), which
directly correlatedwith the development ofmultifunctional CD8+T-
cell responses in three of these patients (24). So far, to our knowledge,
no study exists on the use of human mDCs for anti-
Aspergillus immunotherapy.
In this study, we propose two Aspergillus proteins, CcpA
and Shm2, as potential candidates for the development of aFrontiers in Immunology | www.frontiersin.org 5dendritic cell based anti-Aspergillus immunotherapy. CcpA is a
fungus-specific, 25.5 kDa amphiphilic protein highly abundant
in the conidial cell wall but disappearing during the
germination process. CcpA is required for fungal virulence in
immunocompromised mice with IPA, positioning the protein as
a potential target for immunotherapy (11). Shm2 is a ubiquitous,
51.9 kDa protein found in all pro- and eukaryotes, and plays a
central role in providing one-carbon units for biosynthetic
processes (25). Shm2 is present on the surface of A. fumigatus
germinating conidia and hyphae (26), was found to trigger IgG
responses in sera of patients with invasive aspergillosis (9), and is
a strong elicitor of memory T cell responses (9).A
B C
FIGURE 1 | Maturation profiles of mDCs and moDCs stimulated with A. fumigatus antigens. (A)mDCs and moDCs were stimulated for 18 h with 5 µg/mL Aspergillus
proteins Shm2 (red columns) or CcpA (blue columns), 50 µg/mL AfuLy (green columns), or plain medium (grey columns). Geometric mean fluorescence intensity values of
surface maturation and activation markers were determined by flow cytometry. Means and standard deviations based on three independent donors are shown. The two-
sided paired t-test was used for significance testing (stimulated versus unstimulated cells). ▪ p < 0.1, *p < 0.05. (B, C) Heat maps comparing activation marker expression in
antigen-pulsed and unstimulated mDCs from three additional donors depending on the protein concentration (B) and incubation period (C).May 2021 | Volume 12 | Article 659752
Page et al. Antigen-Pulsed mDCs Induce Anti-Aspergillus ResponseFIGURE 2 | Cytokine profiles of A. fumigatus antigen-stimulated mDCs and moDCs. mDCs and moDCs were stimulated for 18 h with 5 µg/mL Aspergillus
proteins Shm2 or CcpA, 50 µg/mL AfuLy, or plain medium (unstimulated). Cytokine concentrations in the supernatants were quantified using an 8-plex
cytokine assay (data for IL-17A not shown, < 3 pg/mL for all conditions and donors). DCs from three independent donors were tested. Mean cytokine
concentrations and standard deviations are shown. RM one-way ANOVA with Dunnett’s multiple comparison test (versus unstimulated cells). ▪ p < 0.1,
*p < 0.05, **p < 0.01.Frontiers in Immunology | www.frontiersin.org May 2021 | Volume 12 | Article 6597526
Page et al. Antigen-Pulsed mDCs Induce Anti-Aspergillus ResponseInterestingly, our data revealed higher maturation levels of
mDCs pulsed with CcpA than Shm2 and greater IFN-g secretion
of autologous T cells co-cultured with CcpA-pulsed mDCs.
Moreover, stronger enhancement of T-cell proliferation was
observed upon co-culture with CcpA-pulsed mDCs thanFrontiers in Immunology | www.frontiersin.org 7Shm2-pulsed mDCs. Furthermore, compared with Shm2,
CcpA induced strong expression of the homing receptor CCR7
in ex vivo mDCs, suggesting that CcpA-pulsed mDCs are able to
migrate to the lymph nodes and activate an antigen specific




FIGURE 3 | T-cell activation in co-cultures with antigen-loaded mDCs or moDCs. (A) mDCs and moDCs were loaded for 18 h with 5 µg/mL Shm2, 5 µg/mL CcpA,
or 50 µg/mL AfuLy or kept in antigen-free medium (unstimulated). Subsequently, DCs were co-cultured with autologous T cells to quantify IFN-g release by ELISpot
and T-cell proliferation by a CFSE assay. (B) Images of ELISpot wells with cells from one representative donor are shown. (C) Mean spot forming cell (SFC) counts
per 1×106 T-cells and standard deviations are provided (n = 4). RM one-way ANOVA with Dunnett’s multiple comparison test (versus T-cells co-cultured with
unstimulated DCs). ▪ p < 0.1, *p < 0.05, **p < 0.01, ***p < 0.001. (D) Frequencies of CFSElow CD4+ and CD8+ T-cells in DC/T-cell co-cultures were measured by
flow cytometry. As a proliferation control, T-cells were stimulated with Dynabeads CD3/CD28 T-cell Expander. Mean percentages of proliferating T-cells and
standard deviations are shown (n = 2).May 2021 | Volume 12 | Article 659752
Page et al. Antigen-Pulsed mDCs Induce Anti-Aspergillus ResponseA. fumigatus belongs to the group of pathogens whose
antigens are predominantly presented via class II MHC
molecules. Accordingly, strong proliferation of MHC class II-
restricted CD4+ T-helper cells was found upon stimulation by
mDCs pulsed with CcpA or Shm2. However, we also observed
considerable proliferation of MHC class I-restricted CD8+
cytotoxic T cells, which may be explained by cross
presentation. For cross presentation, extracellular antigens are
internalized into the cytosol, processed, and loaded on MHC
class I molecules (29). Interestingly, unlike bacteria and viruses,
fungi can elicit long-term CD8+ T cell memory that is
maintained without CD4+ T cell help or persistent antigen
(30). In agreement with this hypothesis, both A. fumigatus
proteins moderately induced class I MHC expression on mDCs.
The mycelial lysate evoked neither significant maturation of
mDCs nor meaningful cytokine secretion. This observation may
be due to the presence of metabolites which inhibit DC
activation. As an example, Stanzani and colleagues described
that gliotoxin in cell wall lysates of A. fumigatus has an
immunosuppressive effect that specifically results in functional
impairment of moDCs (8). In addition, galactosaminogalactan,
also present in A. fumigatus lysates, exerts immunomodulatory
effects through the modulation of cytokine production, e.g., by
modulating the IL-1 signaling pathway that is crucial for DC
activation (31, 32). Furthermore, the commercial lysate used in
this study might contain various unknown additives, such as
stabilizers and preservatives, which could additionally inhibitFrontiers in Immunology | www.frontiersin.org 8DCs (and neutrophils). Nonetheless, T cells co-cultured with A.
fumigatus lysate-pulsed mDCs released IFN-g and proliferated. If
high affinity compounds from the T-cell-optimized lysate are
directly loaded to surface MHC molecules, T cells may be
stimulated by lysate-pulsed mDCs without induction of
significant mDC maturation and cytokine secretion (13).
Considering such lysates for ex vivo DC pulsing, co-
stimulation with adjuvants may be warranted to elicit optimal
maturation marker induction and cytokine secretion (33, 34).
Our study revealed important data about the in vitro interplay
between human primary mDCs and A. fumigatus antigens focusing
on molecular and functional mechanisms, which in future might
allow the development of immunomodulators for more effective
antifungal immunotherapy. This includes additional in vitro and in
vivo studies on the potential use of appropriate adjuvants for mDC
activation, such as TLR ligands (e.g., Pam3CDK4 or CpG-
containing oligonucleotides) (35), the combined use of mDCs and
autologous pDCs (36), or the exploitation of the potential
immunomodulatory effects of antifungals, especially
echinocandins, on ex vivo-pulsed mDCs. Although a GMP-grade
medium was used for DC culture and stimulation in this study,
further standardization of the antigens and protocols for future
GMP-compliant products will be needed. In addition, further
studies are required using mammalian models to evaluate the
persistence of ex vivo-stimulated mDCs in vivo, their capacity to
migrate to the lymph nodes, as well as their safety and potential
immunogenic potential. Future in vivo studies should also includeA
B
FIGURE 4 | Stimulatory activity of DC supernatants on A. fumigatus-induced oxidative burst in allogeneic PMNs. (A) mDCs and moDCs were loaded for 18 h with 5
µg/mL Shm2, 5 µg/mL CcpA, or 50 µg/mL AfuLy or kept in antigen-free medium (unstimulated). Supernatants were collected and cryopreserved. Allogeneic PMNs
(1×105/well) were co-cultured with A. fumigatus germ tubes (5×104/well) in medium supplemented with diluted DC supernatants, with the medium of each well
containing the metabolites from 2.5×104 DCs. ROS release was quantified using a DCF-based assay. (B) Two-hour AUC values of relative fluorescence/time curves
were determined and normalized to unstimulated PMNs incubated in medium containing supernatants from unstimulated DCs. Mean relative AUCs based on 9
PMN/DC combinations (3 DC donors × 3 PMN donors) and standard deviations are shown. RM one-way ANOVA with Dunnett’s multiple comparison test (versus
PMN/germ tube co-cultures with unstimulated DC supernatants). ▪ p < 0.1, *p < 0.05, **p < 0.01, ***p < 0.001.May 2021 | Volume 12 | Article 659752
Page et al. Antigen-Pulsed mDCs Induce Anti-Aspergillus Responsedirect comparisons of the feasibility, safety, and efficacy of ex vivo-
pulsed mDCs with other potentially promising cell therapeutics
(e.g., adoptive T-cell transfer or mold-reactive CAR T-cells) (4, 37,
38) and non-cellular immune enhancement strategies such as
immune checkpoint blockade (39).
Despite these limitations and need for further research, the
observed broad pro-inflammatory cytokine spectrum,
upregulation of co-stimulatory molecules and MHC complexes,
as well as subsequent activation of T-cell proliferation, and
neutrophilic oxidative burst, position mDCs as a potential tool
for anti-Aspergillus immunotherapy. Furthermore, our findings
suggest that Shm2, and particularly CcpA, are promising
candidates for the development of an antigen cocktail to obtain
functional ex vivo mDCs for adoptive transfer approaches.DATA AVAILABILITY STATEMENT
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